candesartan
| SMILES | CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O |
| InChIKey | HTQMVQVXFRQIKW-UHFFFAOYSA-N |
Chemical properties
| Hydrogen bond acceptors | 7 |
| Hydrogen bond donors | 2 |
| Rotatable bonds | 7 |
| Molecular weight (Da) | 440.2 |
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | Yes |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| AT1 | AGTR1 | Human | Angiotensin | A | pKd | 10.29 | 10.29 | 10.29 | Guide to Pharmacology |
| AT1 | AGTRA | Rat | Angiotensin | A | pKd | 8.0 | 8.25 | 8.5 | ChEMBL |
| α2B | ADA2B | Human | Adrenoceptors | A | pKi | 5.76 | 5.76 | 5.76 | ChEMBL |
| AT1 | AGTR1 | Human | Angiotensin | A | pKi | 7.98 | 8.22 | 8.46 | ChEMBL |
| β3 | ADRB3 | Human | Adrenoceptors | A | pKi | 5.5 | 5.5 | 5.5 | ChEMBL |
| A3 | AA3R | Human | Adenosine | A | pKi | 6.16 | 6.16 | 6.16 | ChEMBL |
| AT1 | AGTR1 | Rabbit | Angiotensin | A | pKi | 9.19 | 9.19 | 9.19 | ChEMBL |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| AT1 | AGTR1 | Human | Angiotensin | A | pIC50 | 9.49 | 9.61 | 9.72 | Guide to Pharmacology |
| AT1 | AGTR1 | Bovine | Angiotensin | A | pIC50 | 6.96 | 6.96 | 6.96 | ChEMBL |
| α2B | ADA2B | Human | Adrenoceptors | A | pIC50 | 5.42 | 5.42 | 5.42 | ChEMBL |
| AT1 | AGTR1 | Human | Angiotensin | A | pIC50 | 6.96 | 8.03 | 9.16 | ChEMBL |
| β3 | ADRB3 | Human | Adrenoceptors | A | pIC50 | 5.37 | 5.37 | 5.37 | ChEMBL |
| BLT2 | LT4R2 | Human | Leukotriene | A | pEC50 | 4.82 | 4.82 | 4.82 | ChEMBL |
| A3 | AA3R | Human | Adenosine | A | pIC50 | 5.91 | 5.91 | 5.91 | ChEMBL |
| AT1 | AGTR1 | Rabbit | Angiotensin | A | pIC50 | 7.55 | 7.55 | 7.55 | ChEMBL |